Flynn Paul R
SEC CIK 1850141 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DXCM | Dexcom | EVP, Gbl Revenue | 48.9K | — | $2.50M | 10 | 2021-09-09 | 2023-12-18 |
Most active insiders at DXCM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SAYER KEVIN R | Executive COB, Dir | — | $8.30M |
| 2 | Leach Jacob Steven | Pres, COO | $1.00M | — |
| 3 | Brown Michael Jon | EVP, CLO | — | $873.4K |
| 4 | Coleman Jon | EVP, Chief Commercial Off | — | $722.6K |
| 5 | AUGUSTINOS NICHOLAS | Dir | — | $679.8K |
| 6 | FOLETTA MARK G | Dir | — | $627.2K |
| 7 | Collins Richard Alexander | Dir | — | $389.4K |
| 8 | Sylvain Jereme M | EVP, Chief Financal Off | — | $302.9K |
| 9 | Heller Bridgette P | Dir | — | $277.7K |
| 10 | Stern Sadie | EVP, Chief HR Off | — | $226.7K |
Flynn Paul R made no open-market trades at DXCM in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-18 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | D - Sale to Iss | $121.85 | -3,163 | 48.9K | -6% | -$385.4K | |
| 2023-04-18 | 2023-04-17 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | S - Sale | $120.00 | -2,781 | 52.1K | -5% | -$333.7K | |
| 2023-03-14 | 2023-03-13 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | S - Sale | $106.27 | -2,782 | 54.9K | -5% | -$295.6K | |
| M | 2023-03-14 | 2023-03-10 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | D - Sale to Iss | $111.40 | -16.8K | 69.0K | -20% | -$1.88M |
| 2023-03-10 | 2023-03-08 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | A - Grant | $0.00 | +18.8K | 74.5K | +34% | $0 | |
| 2022-12-08 | 2022-12-08 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | S - Sale | $123.50 | -8,988 | 55.7K | -14% | -$1.11M | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | D - Sale to Iss | $406.06 | -2,967 | 17.0K | -15% | -$1.20M |
| 2022-03-10 | 2022-03-08 | DXCM | Dexcom | Flynn Paul R | EVP Gbl Revenue | A - Grant | $0.00 | +5,297 | 19.1K | +38% | $0 | |
| 2021-12-17 | 2021-12-15 | DXCM | Dexcom | Flynn Paul R | EVP, Gbl Revenue | A - Grant | $0.00 | +2,925 | 13.9K | +27% | $0 | |
| M | 2021-09-13 | 2021-09-09+ | DXCM | Dexcom | Flynn Paul R | EVP, Gbl Revenue | S - Sale | $549.07 | -1,378 | 10.9K | -11% | -$756.6K |
Purchase Sale Sale after option exercise All abbreviations